TCM
Tekla Capital Management’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $1.49M | Hold |
41,852
| – | – | 0.06% | 119 |
|
2023
Q1 | $1.49M | Hold |
41,852
| – | – | 0.06% | 131 |
|
2022
Q4 | $1.47M | Hold |
41,852
| – | – | 0.06% | 124 |
|
2022
Q3 | $1.23M | Buy |
+41,852
| New | +$1.23M | 0.05% | 126 |
|
2020
Q4 | – | Sell |
-32,400
| Closed | -$1.22M | – | 209 |
|
2020
Q3 | $1.22M | Sell |
32,400
-187,863
| -85% | -$7.07M | 0.05% | 173 |
|
2020
Q2 | $8.99M | Buy |
220,263
+13,395
| +6% | +$546K | 0.34% | 62 |
|
2020
Q1 | $7.84M | Sell |
206,868
-50,180
| -20% | -$1.9M | 0.35% | 57 |
|
2019
Q4 | $12.1M | Buy |
257,048
+25,290
| +11% | +$1.19M | 0.46% | 47 |
|
2019
Q3 | $9.89M | Buy |
231,758
+13,058
| +6% | +$557K | 0.43% | 56 |
|
2019
Q2 | $8.75M | Hold |
218,700
| – | – | 0.36% | 63 |
|
2019
Q1 | $9.14M | Hold |
218,700
| – | – | 0.37% | 58 |
|
2018
Q4 | $8.36M | Hold |
218,700
| – | – | 0.36% | 60 |
|
2018
Q3 | $8.79M | Sell |
218,700
-140,300
| -39% | -$5.64M | 0.32% | 70 |
|
2018
Q2 | $14.5M | Sell |
359,000
-35,749
| -9% | -$1.44M | 0.55% | 42 |
|
2018
Q1 | $15.4M | Buy |
394,749
+35,749
| +10% | +$1.4M | 0.6% | 40 |
|
2017
Q4 | $12.7M | Hold |
359,000
| – | – | 0.49% | 45 |
|
2017
Q3 | $14.6M | Hold |
359,000
| – | – | 0.52% | 39 |
|
2017
Q2 | $15.5M | Hold |
359,000
| – | – | 0.57% | 36 |
|
2017
Q1 | $15.1M | Hold |
359,000
| – | – | 0.59% | 36 |
|
2016
Q4 | $13.8M | Hold |
359,000
| – | – | 0.59% | 38 |
|
2016
Q3 | $15.5M | Sell |
359,000
-75,200
| -17% | -$3.24M | 0.6% | 39 |
|
2016
Q2 | $18.8M | Buy |
434,200
+149,200
| +52% | +$6.47M | 0.77% | 32 |
|
2016
Q1 | $11.6M | Hold |
285,000
| – | – | 0.49% | 52 |
|
2015
Q4 | $11.5M | Hold |
285,000
| – | – | 0.42% | 55 |
|
2015
Q3 | $11M | Buy |
+285,000
| New | +$11M | 0.39% | 49 |
|